We are seeking highly motivated postdoctoral candidates who are interested in translational solid tumor research.
The Ellis-Kavuri lab focuses on studying the functional and clinical impact of poor prognosis tyrosine kinase mutations identified from cancer genome sequencing. We use a variety of preclinical models including cancer cell lines, Organoid cultures, patient-derived xenografts (PDXs), and Genetically engineered mouse models (GEMM). Drs. Kavuri and Matthew Ellis' (Director of Breast center) lab made significant contributions on translating genome-sequencing findings into successful phase II clinical trials.
(Bose. R and Kavuri. SM, Cancer Discovery, 2013; Kavuri. SM et al, Cancer Discovery, 2015; Ben-Baruch NE. et al, JNCCN, 2015; Ma. C et al, 2017, CCR; Huang. Kl.et al, Nature Communication, 2017). Our research is supported by Susan. G. Komen, CPRIT, and multiple Department of Defense grants (DOD).
The candidates are expected to establish independent research projects and to generate high impact publications, which should provide the postdoctoral fellows with an excellent opportunity for further career development in academia.
We invite you to learn more about our benefits: https://www.bcm.edu/careers/benefits